Literature DB >> 3560639

Plasma and urinary catecholamines as related to renal function in man.

K Laederach, P Weidmann.   

Abstract

To assess the relationship between renal plasma flow (ERPF) or glomerular filtration rate (GFR) and the levels of norepinephrine (NE) or epinephrine (E) in plasma or urine in the presence of progressive degrees of non-oliguric renal functional impairment, these variables were assessed simultaneously in 18 normal subjects, 72 with parenchymal kidney disease and 14 with essential hypertension. ERPF and GFR were lower (P less than 0.01 to 0.001) in the groups with renal disease (mean +/- SD, 340 +/- 230 and 68 +/- 43 ml/min/1.73 m2, respectively) or essential hypertension (434 +/- 101 and 97 +/- 25 ml/min/1.73 m2) than normal subjects (597 +/- 133 and 118 +/- 14 ml/min/1.73 m2). Plasma and urinary NE and E did not differ significantly among groups and were unrelated with ERPF or GFR (range 4 to 160 ml/min/1.73 m2), except for reduced (P less than 0.001) urinary NE and E excretion in the presence of a GFR less than 20 ml/min. Subgroups with renal disease and a normal (N = 39) or high blood pressure (N = 33) also were comparable in their plasma and urinary NE and E, while ERPF and GFR tended to be lower in hypertensive patients. It is concluded that a chronic reduction in excretory kidney function may have no relevant impact on circulating levels of NE and E per se, although their urinary excretion falls distinctly at the stage of advanced renal failure. These aspects deserve consideration when pathogenetic or diagnostic studies of catecholamines are performed in normotensive or hypertensive patients with impaired kidney function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3560639     DOI: 10.1038/ki.1987.16

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  The growing problem of intradialytic hypertension.

Authors:  Francesco Locatelli; Andrea Cavalli; Benedetta Tucci
Journal:  Nat Rev Nephrol       Date:  2009-11-24       Impact factor: 28.314

2.  Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines.

Authors:  Mayo Sukegawa; Akiko Noda; Tatsuki Sugiura; Seiichi Nakata; Shigehito Yoshizaki; Taro Soga; Yoshinari Yasuda; Norihisa Iwayama; Shigeru Nakai; Yasuo Koike
Journal:  Clin Cardiol       Date:  2005-11       Impact factor: 2.882

Review 3.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

4.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

5.  Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea.

Authors:  Paula Pinto; Cristina Bárbara; Joseph M Montserrat; Rita S Patarrão; Maria P Guarino; Miguel M Carmo; Maria P Macedo; Cristina Martinho; Rita Dias; Maria J M Gomes
Journal:  BMC Pulm Med       Date:  2013-03-13       Impact factor: 3.317

Review 6.  Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective.

Authors:  Min Kyong Song; Neal M Davies; Basil D Roufogalis; Tom Hsun-Wei Huang
Journal:  J Diabetes Res       Date:  2014-04-13       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.